Karyopharm Therapeutics
KPTI
#8707
Rank
C$0.31 B
Marketcap
C$13.71
Share price
7.22%
Change (1 day)
130.68%
Change (1 year)

Karyopharm Therapeutics (KPTI) Fails to deliver data

Key failure to deliver metrics for Karyopharm Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Karyopharm Therapeutics (KPTI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Karyopharm Therapeutics (KPTI) - since 2025

Volume in USD (price x number of shares), data since 2025

Karyopharm Therapeutics (KPTI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026C$5.66 M-44.85%
2025C$10.27 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Abbott Laboratories
ABT
C$16.85 MC$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$29.84 MC$0.19 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$5.5 MC$63.96 M๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$0.43 MC$28.09 M๐Ÿ‡บ๐Ÿ‡ธ USA